F.M.J. Debruyne
About
In The Last Decade
F.M.J. Debruyne
498 papers receiving 14.3k citations
Hit Papers
Peers
Comparison fields: 5 of 169
- Pulmonary and Respiratory Medicine 6.2k
- Urology 4.7k
- Surgery 3.8k
- Rheumatology 3.3k
- Molecular Biology 3.0k
Countries citing papers authored by F.M.J. Debruyne
This map shows the geographic impact of F.M.J. Debruyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.M.J. Debruyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.M.J. Debruyne more than expected).
Fields of papers citing papers by F.M.J. Debruyne
This network shows the impact of papers produced by F.M.J. Debruyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.M.J. Debruyne. The network helps show where F.M.J. Debruyne may publish in the future.
Co-authorship network of co-authors of F.M.J. Debruyne
This figure shows the co-authorship network connecting the top 25 collaborators of F.M.J. Debruyne. A scholar is included among the top collaborators of F.M.J. Debruyne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.M.J. Debruyne. F.M.J. Debruyne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | Prospective, open-label study of intravenous VPA as a second-line anti-epileptic drug in the treatment of status epilepticus | 2 |
| 4 | 10 | |
| 5 | 10 | |
| 6 | 43 | |
| 7 | 12 | |
| 8 | Results of an European randomized study comparing radical prostatectomy and radocial prostatectomy plus neoadjuvant hormonal combination therapy in stage T2-3NoMo prostatic carcinoma | 3 |
| 9 | Neoadjuvant combined androgen deprivation therapy in locally confined prostate carcinoma: short term results of a European randomized study | 2 |
| 10 | Quality of life of patients with lower urinary tract dysfunction, after treatment with sacral neuromodulation | 6 |
| 11 | Increased expression of a 68-kDa protein in the corpus cavernosum of some men with erectile dysfunction | 1 |
| 12 | 12 | |
| 13 | 29 | |
| 14 | Ultrasonographic findings in patients with nonbacterial prostatitis. | 17 |
| 15 | 3 | |
| 16 | 1 | |
| 17 | 15 | |
| 18 | [Congenital malformations of the stapes area]. | 1 |
| 19 | 136 | |
| 20 | 35 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.